Urology Annals
About UA | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionLogin 
Urology Annals
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 575   Home Print this page  Email this page Small font size Default font size Increase font size
Year : 2019  |  Volume : 11  |  Issue : 2  |  Page : 219-221

Nine-year survival after iterative metastasectomies for renal cell carcinoma

1 Department of Urology, University Hospitals Leuven, Leuven, Belgium; Department of Urology, Santa Maria Hospital, Lisbon, Portugal
2 Department of Urology, University Hospitals Leuven, Leuven, Belgium
3 Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium

Correspondence Address:
Dr. Tiago Ribeiro de Oliveira
Avenida Professor Egas Moniz, Lisbon 1600-190, Portugal

Login to access the Email id

DOI: 10.4103/UA.UA_53_18

PMID: 31040613

Rights and Permissions

We report the case of a 24-year-old male, diagnosed with an incidental T3a papillary renal cell carcinoma (RCC), treated with left laparoscopic radical nephrectomy. After 7 months, nodal recurrence was identified and retroperitoneal lymph node dissection (RPLND) was performed. Four months later, due to local recurrence, the patient underwent salvage RPLND, partial psoas resection and left adrenalectomy, and remained without recurrence during the following 15 months, after which treatment with sunitinib was started due to multiple metastases in pelvic lymph nodes, lungs, and bone. After 4 years of stable disease, progression at the quadratus lumborum and psoas muscles led to subsequent metastasectomy. No evidence of progression was identified for 2 years, after which, despite multimodal treatment (axitinib and radiotherapy to bone lesions), widespread disease progression led to patient death. This uncommon case of prolonged survival with metastatic RCC highlights the possible role of iterative metastasectomies in the management of advanced stage disease, as well as its potential to extend the survival substantially, even when progressive on tyrosine kinase inhibitors.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded123    
    Comments [Add]    

Recommend this journal